drugset / Trial / NCT03527381
Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
RandomizedParallel-groupTriple-blindPrevention
Summary
This prospective randomized study evaluates the nephroprotective effects of exogenous nitric oxide delivered to the extracorporeal circulation circuit during cardiac surgery with cardiopulmonary bypass.
Timeline
- Start
- 2015-09-01
- Primary completion
- 2016-12-25
- Completion
- 2017-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 40 ppm | Other |